You are here

COVID-19

Tiny biologic drug to fight COVID-19 shows promise in animal models

Tiny biologic drug to fight COVID-19 shows promise in animal models

Fierce Biotech

monoclonal antibodies

Flag link:

Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine

Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine

Fierce Pharma

drug manufacturing

Flag link:

Has the Pandemic Impacted Medtech Regulation?

Has the Pandemic Impacted Medtech Regulation?

Medical Devices and Diagnostics Industry

Flag link:

As controversies swirl, CDC director is seen as allowing agency to buckle to political influence

As controversies swirl, CDC director is seen as allowing agency to buckle to political influence

Stat

Robert Redfield

Flag link:

Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier

Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier

BioSpace

Flag link:

AstraZeneca Resumes COVID-19 Vaccine Candidate Trial in South Africa

AstraZeneca Resumes COVID-19 Vaccine Candidate Trial in South Africa

Motley Fool

clinical trials

Flag link:

Only 8% of Americans have a great deal of trust in FDA, poll finds

Only 8% of Americans have a great deal of trust in FDA, poll finds

Beckers Hospital Review

pharma industry

Flag link:

Widespread Distribution of a COVID-19 Vaccine Could Take As Long as 2024

Widespread Distribution of a COVID-19 Vaccine Could Take As Long as 2024

BioSpace

Flag link:

The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19

The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19

Endpoints

Flag link:

How Novavax Is Keeping Up With the Big Players in the Coronavirus Vaccine Race

How Novavax Is Keeping Up With the Big Players in the Coronavirus Vaccine Race

Motley Fool

Flag link:

Early research from 23andMe strengthens link between blood types and Covid-19

Early research from 23andMe strengthens link between blood types and Covid-19

Stat

Flag link:

Pfizer, BioNTech Say COVID-19 Vaccine Might Be Ready by End of October

Pfizer, BioNTech Say COVID-19 Vaccine Might Be Ready by End of October

BioSpace

Flag link:

New report says Covid-19 pandemic has caused historic setbacks in global health

New report says Covid-19 pandemic has caused historic setbacks in global health

Stat

Flag link:

Valneva signs $1.6B supply, development agreement with UK for coronavirus vaccine hopeful

Valneva signs $1.6B supply, development agreement with UK for coronavirus vaccine hopeful

Fierce Pharma

Flag link:

Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time

Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time

Marketwatch

Gilead Sciences

Flag link:

Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease

Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease

Yahoo/Reuters

Neurocrine Biosciences

Parkinson's Disease

Flag link:

Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical Trial

Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical Trial

Motley Fool

Moderna Therapeutics

clinical trials

Flag link:

The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause

The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause

Motley Fool

clinical trials

Flag link:

AstraZeneca, Oxford vaccine study allowed to restart in UK

AstraZeneca, Oxford vaccine study allowed to restart in UK

BioPharma Dive

University of Oxford

clinical trials

Flag link:

Pfizer and BioNTech announce plan to expand Covid-19 vaccine trial

Pfizer and BioNTech announce plan to expand Covid-19 vaccine trial

Stat

clinical trials

Flag link:

Pages